[1]
JOHN GIRIDHARAN IVR and SRINIVASAN R, “REGULATORY CONSIDERATIONS ON ADDITIONAL RISK MINIMIZATION MEASURES IN EUROPE”, Asian J Pharm Clin Res, vol. 18, no. 5, pp. 8–17, May 2025.